BSU Seminar: “Estimation in two-stage adaptive threshold enrichment clinical trials”
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Alison Quenault.
It is now widely acknowledged that a patient’s characteristics may predict how they respond to treatments. Consequently several clinical trials assess the treatment effect in the full population and in biomarker-defined subpopulations. If a biomarker is continuous, a two-stage adaptive threshold enrichment trial incorporates determining the best threshold for defining a subpopulation. Stage 1 data are used to perform an interim analysis to determine if the new treatment is promising in the full population or in a subpopulation defined by one of the candidate biomarker threshold values. In stage 2, recruitment is restricted to the promising subpopulation. In this talk I will describe how to obtain point estimators that adjust for subpopulation selection associated with including stage 1 data in the confirmatory analysis.
This talk is part of the MRC Biostatistics Unit Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|
![[Search]](http://talks.cam.ac.uk/images/search.gif?1209136071)
|![[A-Z Index]](http://talks.cam.ac.uk/images/az.gif?1209136071)
|![[Contact]](http://talks.cam.ac.uk/images/contact.gif?1209136071)
![[University of Cambridge]](http://talks.cam.ac.uk/images/identifier2.gif?1209136071){kind=small}
![[Talks.cam]](http://talks.cam.ac.uk/images/talkslogosmall.gif?1209136071)
Dr Peter Kimani, University of Warwick
Thursday 29 November 2018, 13:30-14:30